 | • レポートコード：QAF27911 • 出版社/出版日：QYResearch / 2021年5月28日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、144ページ • 納品方法：Eメール（即日納品） • 産業分類：医薬品 |
| Single User | ￥592,000 (USD4,000) | ▷ お問い合わせ |
| Multi User | ￥888,000 (USD6,000) | ▷ お問い合わせ |
| Enterprise License | ￥1,184,000 (USD8,000) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 本市場調査資料では、世界の経皮パッチ市場について種類別（サリチル酸メチルベースパッチ、リバスチグミン経皮パッチ、フェンタニル経皮パッチ、リドカインパッチ、ジクロフェナクパッチ、ニコチン経皮パッチ、その他）、用途別（Rxチャンネル、OTCチャンネル）、地域別（アメリカ、ヨーロッパ、中国、日本、東南アジア、インド）に区分して調査し、纏めました。2016年～2027年までの市場規模と予測（販売量、売上、価格）、主要プレイヤーの競争状況・市場シェア・企業情報、製造コスト分析、販売チャネル・流通業者・顧客情報、市場動向・機会・課題などのマーケットデータが記載されています。市場予測データは新型コロナウイルスの影響を反映させました。 ・経皮パッチ市場の概要 ・世界の主要地域別経皮パッチ市場規模2016-2027 ・主要プレイヤーの競争状況・市場シェア ・世界の経皮パッチ市場規模2016-2021：種類別（サリチル酸メチルベースパッチ、リバスチグミン経皮パッチ、フェンタニル経皮パッチ、リドカインパッチ、ジクロフェナクパッチ、ニコチン経皮パッチ、その他） ・世界の経皮パッチ市場予測2012-2027：種類別（サリチル酸メチルベースパッチ、リバスチグミン経皮パッチ、フェンタニル経皮パッチ、リドカインパッチ、ジクロフェナクパッチ、ニコチン経皮パッチ、その他） ・世界の経皮パッチ市場規模2016-2021：用途別（Rxチャンネル、OTCチャンネル） ・世界の経皮パッチ市場予測2012-2027：用途別（Rxチャンネル、OTCチャンネル） ・経皮パッチのアメリカ市場規模と予測2016-2021 ・経皮パッチのヨーロッパ市場規模と予測2016-2021 ・経皮パッチの中国市場規模と予測2016-2021 ・経皮パッチの日本市場規模と予測2016-2021 ・経皮パッチの東南アジア市場規模と予測2016-2021 ・経皮パッチのインド市場規模と予測2016-2021 ・主要プレイヤーの企業情報：事業概要・売上・企業動向 （Hisamitsu Pharmaceutical、Johnson & Johnson、Novartis、UCB Pharma、Mylan、Teva Pharmaceutical、Nitto Denko、Grünenthal、IBSA Group、GSK、Luye Pharma Group、Pfizer、Chattem、Dr Reddy’s Laboratories、Bayer、Mundipharma、Endo International、Beijing Tide Pharmaceutical） ・経皮パッチの製造コスト分析 ・販売チャネル、流通業者、顧客 ・経皮パッチの市場動向・機会・課題 ・調査の結論 |
Transdermal Patch is a medicated adhesive patch that is placed on the skin to deliver a specific dose of medication through the skin and into the bloodstream.Transdermal Patches include fentanyl transdermal patch, nicotine transdermal patch, buprenorphine transdermal patch, clonidine transdermal patch, oxybutynin transdermal patch, estradiol transdermal patch, nitroglycerin transdermal patch and many others.
Transdermal Patches are mainly classified into the following types: Methyl Salicylate-based Patches, Rivastigmine Patches, Fentanyl Patches, Lidocaine Patches, Diclofenac Patches, Nicotine Patches and others. Methyl Salicylate-based segment accounted for the larger part of the revenue market, with 18% in 2019, followed by Lidocaine Patches, with 15%.
Transdermal Patches can delivery drugs through Rx Channel or OTC Channel. The former took a larger market share in 2019, with its sales volume accounting for about 76% of the total.
Hisamitsu Pharmaceutical, Johnson & Johnson, Nitto Denko and Mylan are the Top 4 players of the global Transdermal Patch market. They took up about 42% of the global market in 2019.
Market Analysis and Insights: Global Transdermal Patch Market
The global Transdermal Patch market was valued at US$ 6644.9 in 2020 and will reach US$ 8215.7 million by the end of 2027, growing at a CAGR of 3.6% during 2022-2027.
Global Transdermal Patch Scope and Market Size
The global Transdermal Patch market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Transdermal Patch market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by region (country), by Type and by Application for the period 2016-2027.
Segment by Type
Methyl Salicylate-based Patch
Rivastigmine Transdermal Patch
Fentanyl Transdermal Patch
Lidocaine Patch
Diclofenac Patch
Nicotine Transdermal Patch
Others
Segment by Application
Rx Channel
OTC Channel
The Transdermal Patch market is analysed and market size information is provided by regions (countries). Segment by Application, the Transdermal Patch market is segmented into North America, Europe, China, Japan, Southeast Asia, India and Other Regions.
By Company
Hisamitsu Pharmaceutical
Johnson & Johnson
Novartis
UCB Pharma
Mylan
Teva Pharmaceutical
Nitto Denko
Grünenthal
IBSA Group
GSK
Luye Pharma Group
Pfizer
Chattem
Dr Reddy’s Laboratories
Bayer
Mundipharma
Endo International
Beijing Tide Pharmaceutical
1 Transdermal Patch Market Overview
1.1 Transdermal Patch Product Scope
1.2 Transdermal Patch Segment by Type
1.2.1 Global Transdermal Patch Sales by Type (2016 & 2021 & 2027)
1.2.2 Methyl Salicylate-based Patch
1.2.3 Rivastigmine Transdermal Patch
1.2.4 Fentanyl Transdermal Patch
1.2.5 Lidocaine Patch
1.2.6 Diclofenac Patch
1.2.7 Nicotine Transdermal Patch
1.2.8 Others
1.3 Transdermal Patch Segment by Application
1.3.1 Global Transdermal Patch Sales Comparison by Application (2016 & 2021 & 2027)
1.3.2 Rx Channel
1.3.3 OTC Channel
1.4 Transdermal Patch Market Estimates and Forecasts (2016-2027)
1.4.1 Global Transdermal Patch Market Size in Value Growth Rate (2016-2027)
1.4.2 Global Transdermal Patch Market Size in Volume Growth Rate (2016-2027)
1.4.3 Global Transdermal Patch Price Trends (2016-2027)
2 Transdermal Patch Estimates and Forecasts by Region
2.1 Global Transdermal Patch Market Size by Region: 2016 VS 2021 VS 2027
2.2 Global Transdermal Patch Retrospective Market Scenario by Region (2016-2021)
2.2.1 Global Transdermal Patch Sales Market Share by Region (2016-2021)
2.2.2 Global Transdermal Patch Revenue Market Share by Region (2016-2021)
2.3 Global Transdermal Patch Market Estimates and Forecasts by Region (2022-2027)
2.3.1 Global Transdermal Patch Sales Estimates and Forecasts by Region (2022-2027)
2.3.2 Global Transdermal Patch Revenue Forecast by Region (2022-2027)
2.4 Geographic Market Analysis: Market Facts & Figures
2.4.1 North America Transdermal Patch Estimates and Projections (2016-2027)
2.4.2 Europe Transdermal Patch Estimates and Projections (2016-2027)
2.4.3 China Transdermal Patch Estimates and Projections (2016-2027)
2.4.4 Japan Transdermal Patch Estimates and Projections (2016-2027)
2.4.5 Southeast Asia Transdermal Patch Estimates and Projections (2016-2027)
2.4.6 India Transdermal Patch Estimates and Projections (2016-2027)
3 Global Transdermal Patch Competition Landscape by Players
3.1 Global Top Transdermal Patch Players by Sales (2016-2021)
3.2 Global Top Transdermal Patch Players by Revenue (2016-2021)
3.3 Global Transdermal Patch Market Share by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Transdermal Patch as of 2020)
3.4 Global Transdermal Patch Average Price by Company (2016-2021)
3.5 Manufacturers Transdermal Patch Manufacturing Sites, Area Served, Product Type
3.6 Manufacturers Mergers & Acquisitions, Expansion Plans
4 Global Transdermal Patch Market Size by Type
4.1 Global Transdermal Patch Historic Market Review by Type (2016-2021)
4.1.1 Global Transdermal Patch Sales Market Share by Type (2016-2021)
4.1.2 Global Transdermal Patch Revenue Market Share by Type (2016-2021)
4.1.3 Global Transdermal Patch Price by Type (2016-2021)
4.2 Global Transdermal Patch Market Estimates and Forecasts by Type (2022-2027)
4.2.1 Global Transdermal Patch Sales Forecast by Type (2022-2027)
4.2.2 Global Transdermal Patch Revenue Forecast by Type (2022-2027)
4.2.3 Global Transdermal Patch Price Forecast by Type (2022-2027)
5 Global Transdermal Patch Market Size by Application
5.1 Global Transdermal Patch Historic Market Review by Application (2016-2021)
5.1.1 Global Transdermal Patch Sales Market Share by Application (2016-2021)
5.1.2 Global Transdermal Patch Revenue Market Share by Application (2016-2021)
5.1.3 Global Transdermal Patch Price by Application (2016-2021)
5.2 Global Transdermal Patch Market Estimates and Forecasts by Application (2022-2027)
5.2.1 Global Transdermal Patch Sales Forecast by Application (2022-2027)
5.2.2 Global Transdermal Patch Revenue Forecast by Application (2022-2027)
5.2.3 Global Transdermal Patch Price Forecast by Application (2022-2027)
6 North America Transdermal Patch Market Facts & Figures
6.1 North America Transdermal Patch Sales by Company
6.1.1 North America Transdermal Patch Sales by Company (2016-2021)
6.1.2 North America Transdermal Patch Revenue by Company (2016-2021)
6.2 North America Transdermal Patch Sales Breakdown by Type
6.2.1 North America Transdermal Patch Sales Breakdown by Type (2016-2021)
6.2.2 North America Transdermal Patch Sales Breakdown by Type (2022-2027)
6.3 North America Transdermal Patch Sales Breakdown by Application
6.3.1 North America Transdermal Patch Sales Breakdown by Application (2016-2021)
6.3.2 North America Transdermal Patch Sales Breakdown by Application (2022-2027)
7 Europe Transdermal Patch Market Facts & Figures
7.1 Europe Transdermal Patch Sales by Company
7.1.1 Europe Transdermal Patch Sales by Company (2016-2021)
7.1.2 Europe Transdermal Patch Revenue by Company (2016-2021)
7.2 Europe Transdermal Patch Sales Breakdown by Type
7.2.1 Europe Transdermal Patch Sales Breakdown by Type (2016-2021)
7.2.2 Europe Transdermal Patch Sales Breakdown by Type (2022-2027)
7.3 Europe Transdermal Patch Sales Breakdown by Application
7.3.1 Europe 144 Sales Breakdown by Application (2016-2021)
7.3.2 Europe 144 Sales Breakdown by Application (2022-2027)
8 China Transdermal Patch Market Facts & Figures
8.1 China Transdermal Patch Sales by Company
8.1.1 China Transdermal Patch Sales by Company (2016-2021)
8.1.2 China Transdermal Patch Revenue by Company (2016-2021)
8.2 China Transdermal Patch Sales Breakdown by Type
8.2.1 China Transdermal Patch Sales Breakdown by Type (2016-2021)
8.2.2 China Transdermal Patch Sales Breakdown by Type (2022-2027)
8.3 China Transdermal Patch Sales Breakdown by Application
8.3.1 China 317 Sales Breakdown by Application (2016-2021)
8.3.2 China 317 Sales Breakdown by Application (2022-2027)
9 Japan Transdermal Patch Market Facts & Figures
9.1 Japan Transdermal Patch Sales by Company
9.1.1 Japan Transdermal Patch Sales by Company (2016-2021)
9.1.2 Japan Transdermal Patch Revenue by Company (2016-2021)
9.2 Japan Transdermal Patch Sales Breakdown by Type
9.2.1 Japan Transdermal Patch Sales Breakdown by Type (2016-2021)
9.2.2 Japan Transdermal Patch Sales Breakdown by Type (2022-2027)
9.3 Japan Transdermal Patch Sales Breakdown by Application
9.3.1 Japan Jan. Sales Breakdown by Application (2016-2021)
9.3.2 Japan Jan. Sales Breakdown by Application (2022-2027)
10 Southeast Asia Transdermal Patch Market Facts & Figures
10.1 Southeast Asia Transdermal Patch Sales by Company
10.1.1 Southeast Asia Transdermal Patch Sales by Company (2016-2021)
10.1.2 Southeast Asia Transdermal Patch Revenue by Company (2016-2021)
10.2 Southeast Asia Transdermal Patch Sales Breakdown by Type
10.2.1 Southeast Asia Transdermal Patch Sales Breakdown by Type (2016-2021)
10.2.2 Southeast Asia Transdermal Patch Sales Breakdown by Type (2022-2027)
10.3 Southeast Asia Transdermal Patch Sales Breakdown by Application
10.3.1 Southeast Asia M Pcs Sales Breakdown by Application (2016-2021)
10.3.2 Southeast Asia M Pcs Sales Breakdown by Application (2022-2027)
11 India Transdermal Patch Market Facts & Figures
11.1 India Transdermal Patch Sales by Company
11.1.1 India Transdermal Patch Sales by Company (2016-2021)
11.1.2 India Transdermal Patch Revenue by Company (2016-2021)
11.2 India Transdermal Patch Sales Breakdown by Type
11.2.1 India Transdermal Patch Sales Breakdown by Type (2016-2021)
11.2.2 India Transdermal Patch Sales Breakdown by Type (2022-2027)
11.3 India Transdermal Patch Sales Breakdown by Application
11.3.1 India Transdermal Patch Sales Breakdown by Application (2016-2021)
11.3.2 India Transdermal Patch Sales Breakdown by Application (2022-2027)
12 Company Profiles and Key Figures in Transdermal Patch Business
12.1 Hisamitsu Pharmaceutical
12.1.1 Hisamitsu Pharmaceutical Corporation Information
12.1.2 Hisamitsu Pharmaceutical Business Overview
12.1.3 Hisamitsu Pharmaceutical Transdermal Patch Sales, Revenue and Gross Margin (2016-2021)
12.1.4 Hisamitsu Pharmaceutical Transdermal Patch Products Offered
12.1.5 Hisamitsu Pharmaceutical Recent Development
12.2 Johnson & Johnson
12.2.1 Johnson & Johnson Corporation Information
12.2.2 Johnson & Johnson Business Overview
12.2.3 Johnson & Johnson Transdermal Patch Sales, Revenue and Gross Margin (2016-2021)
12.2.4 Johnson & Johnson Transdermal Patch Products Offered
12.2.5 Johnson & Johnson Recent Development
12.3 Novartis
12.3.1 Novartis Corporation Information
12.3.2 Novartis Business Overview
12.3.3 Novartis Transdermal Patch Sales, Revenue and Gross Margin (2016-2021)
12.3.4 Novartis Transdermal Patch Products Offered
12.3.5 Novartis Recent Development
12.4 UCB Pharma
12.4.1 UCB Pharma Corporation Information
12.4.2 UCB Pharma Business Overview
12.4.3 UCB Pharma Transdermal Patch Sales, Revenue and Gross Margin (2016-2021)
12.4.4 UCB Pharma Transdermal Patch Products Offered
12.4.5 UCB Pharma Recent Development
12.5 Mylan
12.5.1 Mylan Corporation Information
12.5.2 Mylan Business Overview
12.5.3 Mylan Transdermal Patch Sales, Revenue and Gross Margin (2016-2021)
12.5.4 Mylan Transdermal Patch Products Offered
12.5.5 Mylan Recent Development
12.6 Teva Pharmaceutical
12.6.1 Teva Pharmaceutical Corporation Information
12.6.2 Teva Pharmaceutical Business Overview
12.6.3 Teva Pharmaceutical Transdermal Patch Sales, Revenue and Gross Margin (2016-2021)
12.6.4 Teva Pharmaceutical Transdermal Patch Products Offered
12.6.5 Teva Pharmaceutical Recent Development
12.7 Nitto Denko
12.7.1 Nitto Denko Corporation Information
12.7.2 Nitto Denko Business Overview
12.7.3 Nitto Denko Transdermal Patch Sales, Revenue and Gross Margin (2016-2021)
12.7.4 Nitto Denko Transdermal Patch Products Offered
12.7.5 Nitto Denko Recent Development
12.8 Grünenthal
12.8.1 Grünenthal Corporation Information
12.8.2 Grünenthal Business Overview
12.8.3 Grünenthal Transdermal Patch Sales, Revenue and Gross Margin (2016-2021)
12.8.4 Grünenthal Transdermal Patch Products Offered
12.8.5 Grünenthal Recent Development
12.9 IBSA Group
12.9.1 IBSA Group Corporation Information
12.9.2 IBSA Group Business Overview
12.9.3 IBSA Group Transdermal Patch Sales, Revenue and Gross Margin (2016-2021)
12.9.4 IBSA Group Transdermal Patch Products Offered
12.9.5 IBSA Group Recent Development
12.10 GSK
12.10.1 GSK Corporation Information
12.10.2 GSK Business Overview
12.10.3 GSK Transdermal Patch Sales, Revenue and Gross Margin (2016-2021)
12.10.4 GSK Transdermal Patch Products Offered
12.10.5 GSK Recent Development
12.11 Luye Pharma Group
12.11.1 Luye Pharma Group Corporation Information
12.11.2 Luye Pharma Group Business Overview
12.11.3 Luye Pharma Group Transdermal Patch Sales, Revenue and Gross Margin (2016-2021)
12.11.4 Luye Pharma Group Transdermal Patch Products Offered
12.11.5 Luye Pharma Group Recent Development
12.12 Pfizer
12.12.1 Pfizer Corporation Information
12.12.2 Pfizer Business Overview
12.12.3 Pfizer Transdermal Patch Sales, Revenue and Gross Margin (2016-2021)
12.12.4 Pfizer Transdermal Patch Products Offered
12.12.5 Pfizer Recent Development
12.13 Chattem
12.13.1 Chattem Corporation Information
12.13.2 Chattem Business Overview
12.13.3 Chattem Transdermal Patch Sales, Revenue and Gross Margin (2016-2021)
12.13.4 Chattem Transdermal Patch Products Offered
12.13.5 Chattem Recent Development
12.14 Dr Reddy’s Laboratories
12.14.1 Dr Reddy’s Laboratories Corporation Information
12.14.2 Dr Reddy’s Laboratories Business Overview
12.14.3 Dr Reddy’s Laboratories Transdermal Patch Sales, Revenue and Gross Margin (2016-2021)
12.14.4 Dr Reddy’s Laboratories Transdermal Patch Products Offered
12.14.5 Dr Reddy’s Laboratories Recent Development
12.15 Bayer
12.15.1 Bayer Corporation Information
12.15.2 Bayer Business Overview
12.15.3 Bayer Transdermal Patch Sales, Revenue and Gross Margin (2016-2021)
12.15.4 Bayer Transdermal Patch Products Offered
12.15.5 Bayer Recent Development
12.16 Mundipharma
12.16.1 Mundipharma Corporation Information
12.16.2 Mundipharma Business Overview
12.16.3 Mundipharma Transdermal Patch Sales, Revenue and Gross Margin (2016-2021)
12.16.4 Mundipharma Transdermal Patch Products Offered
12.16.5 Mundipharma Recent Development
12.17 Endo International
12.17.1 Endo International Corporation Information
12.17.2 Endo International Business Overview
12.17.3 Endo International Transdermal Patch Sales, Revenue and Gross Margin (2016-2021)
12.17.4 Endo International Transdermal Patch Products Offered
12.17.5 Endo International Recent Development
12.18 Beijing Tide Pharmaceutical
12.18.1 Beijing Tide Pharmaceutical Corporation Information
12.18.2 Beijing Tide Pharmaceutical Business Overview
12.18.3 Beijing Tide Pharmaceutical Transdermal Patch Sales, Revenue and Gross Margin (2016-2021)
12.18.4 Beijing Tide Pharmaceutical Transdermal Patch Products Offered
12.18.5 Beijing Tide Pharmaceutical Recent Development
13 Transdermal Patch Manufacturing Cost Analysis
13.1 Transdermal Patch Key Raw Materials Analysis
13.1.1 Key Raw Materials
13.1.2 Key Raw Materials Price Trend
13.1.3 Key Suppliers of Raw Materials
13.2 Proportion of Manufacturing Cost Structure
13.3 Manufacturing Process Analysis of Transdermal Patch
13.4 Transdermal Patch Industrial Chain Analysis
14 Marketing Channel, Distributors and Customers
14.1 Marketing Channel
14.2 Transdermal Patch Distributors List
14.3 Transdermal Patch Customers
15 Market Dynamics
15.1 Transdermal Patch Market Trends
15.2 Transdermal Patch Drivers
15.3 Transdermal Patch Market Challenges
15.4 Transdermal Patch Market Restraints
16 Research Findings and Conclusion
17 Appendix
17.1 Research Methodology
17.1.1 Methodology/Research Approach
17.1.2 Data Source
17.2 Author List
17.3 Disclaimer
Table 1. Global Transdermal Patch Sales (US$ Million) Growth Rate by Type (2016 & 2021 & 2027)
Table 2. Global Transdermal Patch Sales ((US$ Million)) Comparison by Application (2016 & 2021 & 2027)
Table 3. Global Transdermal Patch Market Size (US$ Million) by Region: 2016 VS 2021 &2027
Table 4. Global Transdermal Patch Sales (M Pcs) by Region (2016-2021)
Table 5. Global Transdermal Patch Sales Market Share by Region (2016-2021)
Table 6. Global Transdermal Patch Revenue (US$ Million) Market Share by Region (2016-2021))
Table 7. Global Transdermal Patch Revenue Share by Region (2016-2021)
Table 8. Global Transdermal Patch Sales (M Pcs) Forecast by Region (2022-2027)
Table 9. Global Transdermal Patch Sales Market Share Forecast by Region (2022-2027)
Table 10. Global Transdermal Patch Revenue (US$ Million) Forecast by Region (2022-2027)
Table 11. Global Transdermal Patch Revenue Share Forecast by Region (2022-2027)
Table 12. Global Transdermal Patch Sales (M Pcs) of Key Companies (2016-2021)
Table 13. Global Transdermal Patch Sales Share by Company (2016-2021)
Table 14. Global Transdermal Patch Revenue (US$ Million) by Company (2016-2021)
Table 15. Global Transdermal Patch Revenue Share by Company (2016-2021)
Table 16. Global Transdermal Patch by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Transdermal Patch as of 2020)
Table 17. Global Transdermal Patch Average Price (USD/Pc) of Key Company (2016-2021)
Table 18. Manufacturers Transdermal Patch Manufacturing Sites and Area Served
Table 19. Manufacturers Transdermal Patch Product Type
Table 20. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 21. Global Transdermal Patch Sales (M Pcs) by Type (2016-2021)
Table 22. Global Transdermal Patch Sales Share by Type (2016-2021)
Table 23. Global Transdermal Patch Revenue (US$ Million) Market Share by Type (2016-2021)
Table 24. Global Transdermal Patch Price (USD/Pc) by Type (2016-2021)
Table 25. Global Transdermal Patch Sales Share by Type (2022-2027)
Table 26. Global Transdermal Patch Revenue (US$ Million) Market Share by Type (2022-2027)
Table 27. Global Transdermal Patch Revenue Share by Type (2022-2027)
Table 28. Global Transdermal Patch Price (USD/Pc) by Type (2022-2027)
Table 29. Global Transdermal Patch Sales (M Pcs) by Application (2016-2021)
Table 30. Global Transdermal Patch Sales Share by Application (2016-2021)
Table 31. Global Transdermal Patch Revenue (US$ Million) Market Share by Application (2016-2021)
Table 32. Global Transdermal Patch Price (USD/Pc) by Application (2016-2021)
Table 33. Global Transdermal Patch Sales (M Pcs) by Application (2022-2027)
Table 34. Global Transdermal Patch Sales Share by Application (2022-2027)
Table 35. Global Transdermal Patch Revenue (US$ Million) Market Share by Application (2022-2027)
Table 36. Global Transdermal Patch Revenue Share by Application (2022-2027)
Table 37. Global Transdermal Patch Price (USD/Pc) by Application (2022-2027)
Table 38. North America Transdermal Patch Sales (M Pcs) by Company (2016-2021)
Table 39. North America Transdermal Patch Sales Market Share by Company (2016-2021)
Table 40. North America Transdermal Patch Revenue by Company (2016-2021) & (US$ Million)
Table 41. North America Transdermal Patch Revenue Market Share by Company (2016-2021)
Table 42. North America Transdermal Patch Sales by Type (2016-2021) & (M Pcs)
Table 43. North America Transdermal Patch Sales Market Share by Type (2016-2021)
Table 44. North America Transdermal Patch Sales by Type (2022-2027) & (M Pcs)
Table 45. North America Transdermal Patch Sales Market Share by Type (2022-2027)
Table 46. North America Transdermal Patch Sales by Application (2016-2021) & (M Pcs)
Table 47. North America Transdermal Patch Sales Market Share by Application (2016-2021)
Table 48. North America Transdermal Patch Sales by Application (2022-2027) & (M Pcs)
Table 49. North America Transdermal Patch Sales Market Share by Application (2022-2027)
Table 50. Europe Transdermal Patch Sales (M Pcs) by Company (2016-2021)
Table 51. Europe Transdermal Patch Sales Market Share by Company (2016-2021)
Table 52. Europe Transdermal Patch Revenue by Company (2016-2021) & (US$ Million)
Table 53. Europe Transdermal Patch Revenue Market Share by Company (2016-2021)
Table 54. Europe Transdermal Patch Sales by Type (2016-2021) & (M Pcs)
Table 55. Europe Transdermal Patch Sales Market Share by Type (2016-2021)
Table 56. Europe Transdermal Patch Sales by Type (2022-2027) & (M Pcs)
Table 57. Europe Transdermal Patch Sales Market Share by Type (2022-2027)
Table 58. Europe Transdermal Patch Sales by Application (2016-2021) & (M Pcs)
Table 59. Europe Transdermal Patch Sales Market Share by Application (2016-2021)
Table 60. Europe Transdermal Patch Sales by Application (2022-2027) & (M Pcs)
Table 61. Europe Transdermal Patch Sales Market Share by Application (2022-2027)
Table 62. China Transdermal Patch Sales (M Pcs) by Company (2016-2021)
Table 63. China Transdermal Patch Sales Market Share by Company (2016-2021)
Table 64. China Transdermal Patch Revenue by Company (2016-2021) & (US$ Million)
Table 65. China Transdermal Patch Revenue Market Share by Company (2016-2021)
Table 66. China Transdermal Patch Sales by Type (2016-2021) & (M Pcs)
Table 67. China Transdermal Patch Sales Market Share by Type (2016-2021)
Table 68. China Transdermal Patch Sales by Type (2022-2027) & (M Pcs)
Table 69. China Transdermal Patch Sales Market Share by Type (2022-2027)
Table 70. China Transdermal Patch Sales by Application (2016-2021) & (M Pcs)
Table 71. China Transdermal Patch Sales Market Share by Application (2016-2021)
Table 72. China Transdermal Patch Sales by Application (2022-2027) & (M Pcs)
Table 73. China Transdermal Patch Sales Market Share by Application (2022-2027)
Table 74. Japan Transdermal Patch Sales (M Pcs) by Company (2016-2021)
Table 75. Japan Transdermal Patch Sales Market Share by Company (2016-2021)
Table 76. Japan Transdermal Patch Revenue by Company (2016-2021) & (US$ Million)
Table 77. Japan Transdermal Patch Revenue Market Share by Company (2016-2021)
Table 78. Japan Transdermal Patch Sales by Type (2016-2021) & (M Pcs)
Table 79. Japan Transdermal Patch Sales Market Share by Type (2016-2021)
Table 80. Japan Transdermal Patch Sales by Type (2022-2027) & (M Pcs)
Table 81. Japan Transdermal Patch Sales Market Share by Type (2022-2027)
Table 82. Japan Transdermal Patch Sales by Application (2016-2021) & (M Pcs)
Table 83. Japan Transdermal Patch Sales Market Share by Application (2016-2021)
Table 84. Japan Transdermal Patch Sales by Application (2022-2027) & (M Pcs)
Table 85. Japan Transdermal Patch Sales Market Share by Application (2022-2027)
Table 86. Southeast Asia Transdermal Patch Sales (M Pcs) by Company (2016-2021)
Table 87. Southeast Asia Transdermal Patch Sales Market Share by Company (2016-2021)
Table 88. Southeast Asia Transdermal Patch Revenue by Company (2016-2021) & (US$ Million)
Table 89. Southeast Asia Transdermal Patch Revenue Market Share by Company (2016-2021)
Table 90. Southeast Asia Transdermal Patch Sales by Type (2016-2021) & (M Pcs)
Table 91. Southeast Asia Transdermal Patch Sales Market Share by Type (2016-2021)
Table 92. Southeast Asia Transdermal Patch Sales by Type (2022-2027) & (M Pcs)
Table 93. Southeast Asia Transdermal Patch Sales Market Share by Type (2022-2027)
Table 94. Southeast Asia Transdermal Patch Sales by Application (2016-2021) & (M Pcs)
Table 95. Southeast Asia Transdermal Patch Sales Market Share by Application (2016-2021)
Table 96. Southeast Asia Transdermal Patch Sales by Application (2022-2027) & (M Pcs)
Table 97. Southeast Asia Transdermal Patch Sales Market Share by Application (2022-2027)
Table 98. India Transdermal Patch Sales (M Pcs) by Company (2016-2021)
Table 99. India Transdermal Patch Sales Market Share by Company (2016-2021)
Table 100. India Transdermal Patch Revenue by Company (2016-2021) & (US$ Million)
Table 101. India Transdermal Patch Revenue Market Share by Company (2016-2021)
Table 102. India Transdermal Patch Sales by Type (2016-2021) & (M Pcs)
Table 103. India Transdermal Patch Sales Market Share by Type (2016-2021)
Table 104. India Transdermal Patch Sales by Type (2022-2027) & (M Pcs)
Table 105. India Transdermal Patch Sales Market Share by Type (2022-2027)
Table 106. India Transdermal Patch Sales by Application (2016-2021) & (M Pcs)
Table 107. India Transdermal Patch Sales Market Share by Application (2016-2021)
Table 108. India Transdermal Patch Sales by Application (2022-2027) & (M Pcs)
Table 109. India Transdermal Patch Sales Market Share by Application (2022-2027)
Table 110. Hisamitsu Pharmaceutical Corporation Information
Table 111. Hisamitsu Pharmaceutical Description and Business Overview
Table 112. Hisamitsu Pharmaceutical Transdermal Patch Sales (M Pcs), Revenue (Million USD), Price (USD/Pc) and Gross Margin (2016-2021)
Table 113. Hisamitsu Pharmaceutical Transdermal Patch Product
Table 114. Hisamitsu Pharmaceutical Recent Development
Table 115. Johnson & Johnson Corporation Information
Table 116. Johnson & Johnson Description and Business Overview
Table 117. Johnson & Johnson Transdermal Patch Sales (M Pcs), Revenue (Million USD), Price (USD/Pc) and Gross Margin (2016-2021)
Table 118. Johnson & Johnson Transdermal Patch Product
Table 119. Johnson & Johnson Recent Development
Table 120. Novartis Corporation Information
Table 121. Novartis Description and Business Overview
Table 122. Novartis Transdermal Patch Sales (M Pcs), Revenue (Million USD), Price (USD/Pc) and Gross Margin (2016-2021)
Table 123. Novartis Transdermal Patch Product
Table 124. Novartis Recent Development
Table 125. UCB Pharma Corporation Information
Table 126. UCB Pharma Description and Business Overview
Table 127. UCB Pharma Transdermal Patch Sales (M Pcs), Revenue (Million USD), Price (USD/Pc) and Gross Margin (2016-2021)
Table 128. UCB Pharma Transdermal Patch Product
Table 129. UCB Pharma Recent Development
Table 130. Mylan Corporation Information
Table 131. Mylan Description and Business Overview
Table 132. Mylan Transdermal Patch Sales (M Pcs), Revenue (Million USD), Price (USD/Pc) and Gross Margin (2016-2021)
Table 133. Mylan Transdermal Patch Product
Table 134. Mylan Recent Development
Table 135. Teva Pharmaceutical Corporation Information
Table 136. Teva Pharmaceutical Description and Business Overview
Table 137. Teva Pharmaceutical Transdermal Patch Sales (M Pcs), Revenue (Million USD), Price (USD/Pc) and Gross Margin (2016-2021)
Table 138. Teva Pharmaceutical Transdermal Patch Product
Table 139. Teva Pharmaceutical Recent Development
Table 140. Nitto Denko Corporation Information
Table 141. Nitto Denko Description and Business Overview
Table 142. Nitto Denko Transdermal Patch Sales (M Pcs), Revenue (Million USD), Price (USD/Pc) and Gross Margin (2016-2021)
Table 143. Nitto Denko Transdermal Patch Product
Table 144. Nitto Denko Recent Development
Table 145. Grünenthal Corporation Information
Table 146. Grünenthal Transdermal Patch Sales (M Pcs), Revenue (Million USD), Price (USD/Pc) and Gross Margin (2016-2021)
Table 147. Grünenthal Description and Business Overview
Table 148. Grünenthal Transdermal Patch Product
Table 149. Grünenthal Recent Development
Table 150. IBSA Group Corporation Information
Table 151. IBSA Group Transdermal Patch Sales (M Pcs), Revenue (Million USD), Price (USD/Pc) and Gross Margin (2016-2021)
Table 152. IBSA Group Description and Business Overview
Table 153. IBSA Group Transdermal Patch Product
Table 154. IBSA Group Recent Development
Table 155. GSK Corporation Information
Table 156. GSK Description and Business Overview
Table 157. GSK Transdermal Patch Sales (M Pcs), Revenue (Million USD), Price (USD/Pc) and Gross Margin (2016-2021)
Table 158. GSK Transdermal Patch Product
Table 159. GSK Recent Development
Table 160. Luye Pharma Group Corporation Information
Table 161. Luye Pharma Group Description and Business Overview
Table 162. Luye Pharma Group Transdermal Patch Sales (M Pcs), Revenue (Million USD), Price (USD/Pc) and Gross Margin (2016-2021)
Table 163. Luye Pharma Group Transdermal Patch Product
Table 164. Luye Pharma Group Recent Development
Table 165. Pfizer Corporation Information
Table 166. Pfizer Description and Business Overview
Table 167. Pfizer Transdermal Patch Sales (M Pcs), Revenue (Million USD), Price (USD/Pc) and Gross Margin (2016-2021)
Table 168. Pfizer Transdermal Patch Product
Table 169. Pfizer Recent Development
Table 170. Chattem Corporation Information
Table 171. Chattem Description and Business Overview
Table 172. Chattem Transdermal Patch Sales (M Pcs), Revenue (Million USD), Price (USD/Pc) and Gross Margin (2016-2021)
Table 173. Chattem Transdermal Patch Product
Table 174. Chattem Recent Development
Table 175. Dr Reddy’s Laboratories Corporation Information
Table 176. Dr Reddy’s Laboratories Description and Business Overview
Table 177. Dr Reddy’s Laboratories Transdermal Patch Sales (M Pcs), Revenue (Million USD), Price (USD/Pc) and Gross Margin (2016-2021)
Table 178. Dr Reddy’s Laboratories Transdermal Patch Product
Table 179. Dr Reddy’s Laboratories Recent Development
Table 180. Bayer Corporation Information
Table 181. Bayer Description and Business Overview
Table 182. Bayer Transdermal Patch Sales (M Pcs), Revenue (Million USD), Price (USD/Pc) and Gross Margin (2016-2021)
Table 183. Bayer Transdermal Patch Product
Table 184. Bayer Recent Development
Table 185. Mundipharma Corporation Information
Table 186. Mundipharma Description and Business Overview
Table 187. Mundipharma Transdermal Patch Sales (M Pcs), Revenue (Million USD), Price (USD/Pc) and Gross Margin (2016-2021)
Table 188. Mundipharma Transdermal Patch Product
Table 189. Mundipharma Recent Development
Table 190. Endo International Corporation Information
Table 191. Endo International Description and Business Overview
Table 192. Endo International Transdermal Patch Sales (M Pcs), Revenue (Million USD), Price (USD/Pc) and Gross Margin (2016-2021)
Table 193. Endo International Transdermal Patch Product
Table 194. Endo International Recent Development
Table 195. Beijing Tide Pharmaceutical Corporation Information
Table 196. Beijing Tide Pharmaceutical Description and Business Overview
Table 197. Beijing Tide Pharmaceutical Transdermal Patch Sales (M Pcs), Revenue (Million USD), Price (USD/Pc) and Gross Margin (2016-2021)
Table 198. Beijing Tide Pharmaceutical Transdermal Patch Product
Table 199. Beijing Tide Pharmaceutical Recent Development
Table 200. Production Base and Market Concentration Rate of Raw Material
Table 201. Key Suppliers of Raw Materials
Table 202. Transdermal Patch Distributors List
Table 203. Transdermal Patch Customers List
Table 204. Transdermal Patch Market Trends
Table 205. Transdermal Patch Market Drivers
Table 206. Transdermal Patch Market Challenges
Table 207. Transdermal Patch Market Restraints
Table 208. Research Programs/Design for This Report
Table 209. Key Data Information from Secondary Sources
Table 210. Key Data Information from Primary Sources
List of Figures
Figure 1. Transdermal Patch Product Picture
Figure 2. Global Transdermal Patch Sales Market Share by Type in 2021 & 2027
Figure 3. Type I Product Picture
Figure 4. Type II Product Picture
Figure 5. Global Transdermal Patch Sales Market Share by Application in 2021 & 2027
Figure 6. Rx Channel Examples
Figure 7. OTC Channel Examples
Figure 8. Global Transdermal Patch Sales, (US$ Million), 2016 VS 2021 VS 2027
Figure 9. Global Transdermal Patch Sales Growth Rate (2016-2027) & (US$ Million)
Figure 10. Global Transdermal Patch Sales (M Pcs) Growth Rate (2016-2027)
Figure 11. Global Transdermal Patch Price Trends Growth Rate (2016-2027) (USD/Pc)
Figure 12. Global Transdermal Patch Revenue Market Share by Region: 2016 VS 2021
Figure 13. Global Transdermal Patch Revenue Market Share by Region: 2021 VS 2027
Figure 14. North America Transdermal Patch Revenue (Million USD) Growth Rate (2016-2027)
Figure 15. North America Transdermal Patch Sales (M Pcs) Growth Rate (2016-2027)
Figure 16. Europe Transdermal Patch Revenue (Million USD) Growth Rate (2016-2027)
Figure 17. Europe Transdermal Patch Sales (Million USD) Growth Rate (2016-2027)
Figure 18. China Transdermal Patch Revenue (Million USD) Growth Rate (2016-2027)
Figure 19. China Transdermal Patch Sales (Million USD) and Growth Rate (2016-2027)
Figure 20. Japan Transdermal Patch Revenue (Million USD) Growth Rate (2016-2027)
Figure 21. Japan Transdermal Patch Sales (Million USD) Growth Rate (2016-2027)
Figure 22. Southeast Asia Transdermal Patch Revenue (Million USD) Growth Rate (2016-2027)
Figure 23. Southeast Asia Transdermal Patch Sales (Million USD) Growth Rate (2016-2027)
Figure 24. India Transdermal Patch Revenue (Million USD) Growth Rate (2016-2027)
Figure 25. India Transdermal Patch Sales (Million USD) Growth Rate (2016-2027)
Figure 26. Global 5 Largest Transdermal Patch Players Market Share by Revenue in Transdermal Patch: 2016 & 2020
Figure 27. Transdermal Patch Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2016 VS 2020
Figure 28. Global Transdermal Patch Revenue Share by Type (2016-2021)
Figure 29. Global Transdermal Patch Revenue Growth Rate by Type in 2016 & 2020
Figure 30. Global Transdermal Patch Revenue Share by Application (2016-2021)
Figure 31. Global Transdermal Patch Revenue Growth Rate by Application in 2016 & 2020
Figure 32. North America Transdermal Patch Sales Market Share by Type in 2020
Figure 33. North America Transdermal Patch Sales Market Share by Application in 2020
Figure 34. Europe Transdermal Patch Sales Market Share by Type in 2020
Figure 35. Europe Transdermal Patch Sales Market Share by Application in 2020
Figure 36. China Transdermal Patch Sales Market Share by Type in 2020
Figure 37. China Transdermal Patch Sales Market Share by Application in 2020
Figure 38. Japan Transdermal Patch Sales Market Share by Type in 2020
Figure 39. Japan Transdermal Patch Sales Market Share by Application in 2020
Figure 40. Southeast Asia Transdermal Patch Sales Market Share by Type in 2020
Figure 41. Southeast Asia Transdermal Patch Sales Market Share by Application in 2020
Figure 42. India Transdermal Patch Sales Market Share by Type in 2020
Figure 43. India Transdermal Patch Sales Market Share by Application in 2020
Figure 44. Key Raw Materials Price Trend
Figure 45. Manufacturing Cost Structure of Transdermal Patch
Figure 46. Manufacturing Process Analysis of Transdermal Patch
Figure 47. Transdermal Patch Industrial Chain Analysis
Figure 48. Channels of Distribution
Figure 49. Distributors Profiles
Figure 50. Bottom-up and Top-down Approaches for This Report
Figure 51. Data Triangulation
Figure 52. Key Executives Interviewed